Synopsis of recent research by authors named "Esther Nieder"
- Esther Nieder's research primarily revolves around the evaluation of treatment outcomes and quality of life in adult patients with epilepsy, specifically focusing on drug therapies such as levetiracetam and pregabalin.
- Her 2013 study analyzed the impact of converting from adjunctive levetiracetam treatment to monotherapy, highlighting significant changes in health-related quality of life, anxiety, and depression among the patients.
- In another research effort, Nieder examined the retention rate of pregabalin in a clinical setting for drug-resistant epilepsy, emphasizing the importance of real-world efficacy data alongside controlled clinical trials.